Variation in Sex Characteristics (Restricted Medical Treatment) Act 2023

For section 13 (1) (a), in considering if it is reasonably likely that a prescribed person who is a child would suffer significant harm if the proposed treatment or an alternative treatment option were not undertaken, the assessment committee—

for an individual treatment plan—must consider any wishes the child has communicated in relation to their variation in sex characteristics; and

must disregard any evidence that the treatment needs to be undertaken to reduce discrimination or stigmatisation or a perceived risk of discrimination or stigmatisation.